Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis

GLP-1 receptor agonists (GLP-1RA) and SGLT2 inhibitors (SGLT2i) have been associated with improved glycemic control, body weight loss and favorable changes in cardiovascular risk factors and outcomes. We conducted a systematic review and meta-analysis to evaluate the effects of the addition of GLP-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellana, Marco, Cignarelli, Angelo, Brescia, Francesco, Perrini, Sebastio, Natalicchio, Annalisa, Laviola, Luigi, Giorgino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920368/
https://www.ncbi.nlm.nih.gov/pubmed/31852920
http://dx.doi.org/10.1038/s41598-019-55524-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920368/
https://www.ncbi.nlm.nih.gov/pubmed/31852920
http://dx.doi.org/10.1038/s41598-019-55524-w

Ejemplares similares